OncoSil Medical

(ASX) OSL

Current PriceA$0.57

Market CapA$17.45M

Since IPO (2005)-99%

5 YearN/A

1 Year-39%

1 Month+16%

OncoSil Medical Financials at a Glance

Market Cap

A$17.45M

Revenue (TTM)

A$2.22M

Net Income (TTM)

-A$25.98M

EPS (TTM)

-A$0.95

P/E Ratio

-0.60

Dividend

A$0.00

Beta (Volatility)

0.74 (Low)

Dividend

A$0.00

Beta (Volatility)

0.74 (Low)

Price

A$0.57

Volume

34,579

Open

A$0.55

Price

A$0.57

Volume

34,579

Open

A$0.55

Previous Close

A$0.57

Daily Range

A$0.55 - A$0.60

52-Week Range

A$0.37 - A$2.09

Estimated Earnings Date

Aug 27, 2026

Dividend

A$0.00

Beta (Volatility)

0.74 (Low)

Price

A$0.57

Volume

34,579

Open

A$0.55

Previous Close

A$0.57

Daily Range

A$0.55 - A$0.60

52-Week Range

A$0.37 - A$2.09

Estimated Earnings Date

Aug 27, 2026

OSL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OncoSil Medical

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Nigel Lange

Website

www.oncosil.com.au

Headquarters

Macquarie Park, NSW 2060, AU

OSL Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-12%

Net Income Margin

-10%

Return on Equity

-208%

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

-1.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$17.45M

Shares Outstanding

30.89M

Volume

34.58K

Avg. Volume

121.92K

Financials (TTM)

Gross Profit

-A$1.08M

Operating Income

-A$15.49M

EBITDA

-A$15.06M

Operating Cash Flow

-A$12.06M

Capital Expenditure

-A$14.96K

Free Cash Flow

-A$12.08M

Cash & ST Invst.

A$5.11M

Total Debt

A$69.92K

OncoSil Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$782.90K

+790.1%

Gross Profit

-A$3.22M

-0.0%

Gross Margin

-4.12%

N/A

Market Cap

A$17.45M

N/A

Market Cap/Employee

A$8.73M

N/A

Employees

N/A

Net Income

-A$4.53M

+24.8%

EBITDA

-A$6.94M

-7.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$2.85M

-41.6%

Total Debt

A$42.47K

-60.4%

Accounts Receivable

A$3.27M

+455.0%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

-100.0%

Short Term Debt

A$42.47K

-38.2%

Return on Assets

-1.81%

N/A

Return on Invested Capital

-4.00%

N/A

Free Cash Flow

-A$6.96M

-61.7%

Operating Cash Flow

-A$6.96M

-61.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RHT.AXResonance Health Limited

RHT.AXResonance Health LimitedA$0.04+0.00%

IDT.AXIDT Australia Limited

IDT.AXIDT Australia LimitedA$0.03+3.03%

AT1.AXAtomo Diagnostics Limited

AT1.AXAtomo Diagnostics LimitedA$0.02-5.88%

NTI.AXNeurotech International Limited

NTI.AXNeurotech International LimitedA$0.01+8.33%

TRU.AXTruScreen Group Limited

TRU.AXTruScreen Group LimitedA$0.02+6.67%

IMC.AXImmuron Limited

IMC.AXImmuron LimitedA$0.03-12.82%

HMD.AXHeraMED Limited

HMD.AXHeraMED LimitedA$0.04+2.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About OSL

What is the current price of OncoSil Medical?

OncoSil Medical is trading at A$0.57 per share.

What is the 52-week range for OncoSil Medical?

Over the past 52 weeks, OncoSil Medical has traded between A$0.37 and A$2.09.

How much debt does OncoSil Medical have?

As of the most recent reporting period, OncoSil Medical reported total debt of A$69.92K.

How much cash does OncoSil Medical have on hand?

OncoSil Medical reported A$5.11M in cash and cash equivalents in its most recent financial results.

What is OncoSil Medical’s dividend yield?

OncoSil Medical does not currently have a dividend yield.

OncoSil Medical

OncoSil Medical Financials at a Glance

OSL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About OncoSil Medical

OSL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

OncoSil Medical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OSL

What is the current price of OncoSil Medical?

What is the 52-week range for OncoSil Medical?

How much debt does OncoSil Medical have?

How much cash does OncoSil Medical have on hand?

What is OncoSil Medical’s dividend yield?

Premium Investing Services